Here's What You Need to Know About Restylane Contour and Revance's DAXI, the Two Newest Cosmetic Injectables
1 month ago - By American Board of Cosmetic Surgery
Two new cosmetic injectables-Restylane Contour® and Revance's Botox-like neuromodulator, DaxibotulinumtoxinA®-are set to make waves in the aesthetics community this year. With the demand for dermal fillers and neurotoxins continuing to rise, these products may play a role in advancing the efficacy of cosmetic injections. From how they work and what they can treat to where you can find them, here's what we know so far about these new products. Restylane Contour®: all about the newest cheek filler How does it work? What can it treat? How effective is it? Is Restylane Contour® FDA approved?...
Read more ...
Search by Tags
Aesthetical Botox Injections Set Contour Contouring Hyaluronic Acid Cosmetic Aesthetic Injection Cosmetics Sets News Non-Surgical Abcs American board cosmetic surgery American board of cosmetic surgery Board certified cosmetic surgeon Board certified cosmetic surgery FDA FDA appoved Fillers Fillers news Injectables Nonsurgical cosmetic treatments Restylane Restylane Contour Revance Revance DAXI
The headlines of Care Mag
The Best Alternatives If Retinol Is Too Harsh for Your Skin
Try these ingredients instead.
What to Do This Weekend
Set your intention for August.
The way we train doctors puts their mental health at risk: We need new solutions
This year has shown that being a doctor is no longer just about skill: it's about resilience, stamina, empathy, flexibility and teamwork. The way we educate medics needs to...
CEO of digital therapeutics business Freespira talks about its approach to...
Freespira CEO Dean Sawyer said its FDA cleared digital therapeutic is the first that's proven to significantly reduce or eliminate symptoms of panic attacks, panic disorder...
AC Immune picks up Phase 2-ready drug for Parkinson's in $58M deal with Affiris
AC Immune is bolstering the Parkinson's disease portion of its drug pipeline with a deal to acquire a therapeutic vaccine that Affiris is developing for the disorder...
Veda snags $45M to scale AI data processing platform for payers
The company's data processing platform can help payers comply with the law banning surprise billing, which requires insurers to process all provider directory updates in less...
The $87M push that could make or break our public health data system
If approved by Congress, ONC will receive $87 million for fiscal year 2022. With more funding, prominence, and demands, where should ONC place its focus?
This Underrated Grain May Help Manage Blood Sugar & Prevent Diabetes
Not all grains are created equal.
Is Love At First Sight Real? We Asked Marriage Therapists To Weigh In
The science behind the magic.
If Your Tinder Match Stopped Responding To You, Here's What To Do
It doesn't always happen, but sometimes you start messaging someone on a dating app and you just click. You and your match seem to have endless things to talk about. The...